The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late‐Onset Hypogonadism and Atherogenic Dyslipidemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-5922|33|5|270-274

ISSN： 1755-5914

Source： CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol.33, Iss.5, 2015-10, pp. : 270-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can testosterone level be a good predictor of late‐onset hypogonadism?

By  

ANDROLOGIA (ELECTRONIC), Vol. 47, Iss. 4, 2015-05 ,pp. : 433-437

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence of Late-Onset Hypogonadism in Men with Localized and Metastatic Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 98, Iss. 2, 2016-10 ,pp. : 191-197

Karger

Access to resources Recommend Favorite

Androgen Receptor and Sexual Function

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 2, 2015-02 ,pp. : 381-388

John Wiley & Sons Inc

Access to resources Recommend Favorite

Androgen Replacement Therapy in Late-Onset Hypogonadism: Current Concepts and Controversies – A Mini-Review

By  

Gerontology, Vol. 57, Iss. 3, 2010-08 ,pp. : 193-202

Karger

Access to resources Recommend Favorite

Diabetes mellitus and late‐onset hypogonadism: the role of Glu298Asp endothelial nitric oxide synthase polymorphism

By  

ANDROLOGIA (ELECTRONIC), Vol. 47, Iss. 8, 2015-10 ,pp. : 867-871

John Wiley & Sons Inc

Access to resources Recommend Favorite